SF3B1 and myelodysplastic syndrome: For instance, some data suggest that SF3B1-mutant MDS, characterized by ring sideroblasts (RS), ineffective erythropoiesis, and an indolent clinical course, should be recognized as a distinct nosologic entity (Table 1) [23, 25].